R2 Technology landed a big fish this month when the developer of mammography computer-aided diagnosis (CAD) workstations signed an exclusive OEM supply deal with GE Medical Systems of Milwaukee. GE has agreed to bundle R2's ImageChecker workstation with
R2 Technology landed a big fish this month when the developer of mammography computer-aided diagnosis (CAD) workstations signed an exclusive OEM supply deal with GE Medical Systems of Milwaukee. GE has agreed to bundle R2's ImageChecker workstation with its full-field digital mammography systems under development, and sell both products to customers as part of a complete package.
R2 of Los Altos Hills, CA, developed ImageChecker to provide a backup to mammographers reading digitized exams by flagging suspicious areas. R2 began selling ImageChecker in Europe in 1997, and filed a premarket approval (PMA) application with the Food and Drug Administration later that year.
ImageChecker would complement GE's work in digital mammography. Digital x-ray data collected by GE's digital systems could be fed into ImageChecker for analysis. GE's healthy market share in mammography would ensure a large potential market for ImageChecker.
The agreement does not cover the use of ImageChecker with digitized mammography film, leaving R2 open to securing new OEM relationships for that configuration of its product. R2 at one point had been in discussions with Imation over a distribution deal for ImageChecker, but those talks never developed further (SCAN Special Report 12/97).
R2 officials declined to comment on the GE relationship, as the company is still in a quiet period related to its pending initial public offering. The launch of the IPO is contingent on market conditions, according to a source close to the company.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.